Good Clinical Response to Erlotinib in a Non-Small Cell Lung Cancer Patient Harboring Multiple Brain Metastases and a Double Active Somatic Epidermal Growth Factor Gene Mutation

Publisher： Karger

E-ISSN： 1662-6575|3|2|98-105

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.3, Iss.2, 2010-04, pp. : 98-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discrepancy between the Clinical Image and Pathological Findings of Non-Small Cell Lung Cancer Harboring an Epidermal Growth Factor Receptor Gene Mutation That Was Surgically Resected after Gefitinib Treatment

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-02 ,pp. : 126-131

Karger

Access to resources Recommend Favorite

A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer

By                    

International Journal of Molecular Medicine, Vol. 34, Iss. 2, 2014-01 ,pp. : 464-474

Spandidos Publications

Access to resources Recommend Favorite

Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation

By  

Oncology, Vol. 87, Iss. 4, 2014-07 ,pp. : 215-223

Karger

Access to resources Recommend Favorite

Impact of Smoking History on the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer Harboring Activating Epidermal Growth Factor Receptor Mutations

By  

Oncology, Vol. 89, Iss. 5, 2015-0 ,pp. : 275-280

Karger

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibition and Non-Small Cell Lung cancer

By von Eyben Finn  

Critical Reviews in Clinical Laboratory Sciences, Vol. 43, Iss. 4, 2006-08 ,pp. : 291-323

Informa Healthcare

Access to resources Recommend Favorite